Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Stockholders' Equity (Unaudited)

v3.20.2
Condensed Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Balances at Dec. 31, 2018 $ 66,705   $ 1 $ 126,925   $ (60,221)  
Balance (in shares) at Dec. 31, 2018     12,689        
AccountingStandardsUpdateExtensibleList us-gaap:AccountingStandardsUpdate201807Member         us-gaap:AccountingStandardsUpdate201807Member  
Common stock issued (in shares)     148        
Stock-based compensation $ 7,745     7,745      
Net loss (14,674)         $ (14,674)  
Balances at Mar. 31, 2019 59,797   $ 1 134,670   (74,874)  
Balance (in shares) at Mar. 31, 2019     12,837        
Balances at Dec. 31, 2018 66,705   $ 1 126,925   (60,221)  
Balance (in shares) at Dec. 31, 2018     12,689        
Other comprehensive Income (loss) 51            
Net loss (29,796)            
Balances at Jun. 30, 2019 51,895   $ 1 141,839 $ 51 (89,996)  
Balance (in shares) at Jun. 30, 2019     13,221        
Adoption of accounting standard (See Note 2)   $ 21         $ 21
Balances at January 1, 2019 66,726   $ 1 126,925   (60,200)  
Balances at Mar. 31, 2019 59,797   $ 1 134,670   (74,874)  
Balance (in shares) at Mar. 31, 2019     12,837        
Common stock issued 37     37      
Common stock issued (in shares)     384        
Stock-based compensation 7,132     7,132      
Other comprehensive Income (loss) 51       51    
Net loss (15,122)         (15,122)  
Balances at Jun. 30, 2019 51,895   $ 1 141,839 51 (89,996)  
Balance (in shares) at Jun. 30, 2019     13,221        
Balances at Dec. 31, 2019 33,150   $ 1 150,280 26 (117,157)  
Balance (in shares) at Dec. 31, 2019     13,770        
Common stock issued (in shares)     125        
Stock-based compensation 1,047     1,047      
Other comprehensive Income (loss) (22)       (22)    
Net loss (7,701)         (7,701)  
Balances at Mar. 31, 2020 26,474   $ 1 151,327 4 (124,858)  
Balance (in shares) at Mar. 31, 2020     13,895        
Balances at Dec. 31, 2019 33,150   $ 1 150,280 26 (117,157)  
Balance (in shares) at Dec. 31, 2019     13,770        
Other comprehensive Income (loss) (26)            
Net loss (17,822)            
Balances at Jun. 30, 2020 26,984   $ 4 161,959   (134,979)  
Balance (in shares) at Jun. 30, 2020     38,183        
Balances at Mar. 31, 2020 26,474   $ 1 151,327 4 (124,858)  
Balance (in shares) at Mar. 31, 2020     13,895        
Exercise of warrants 827   $ 1 826      
Exercise of warrants (in shares)     1,838        
Common stock issued pursuant to the vesting of restricted stock units and ESPP 27     27      
Common stock issued pursuant to the vesting of restricted stock units and ESPP (in shares)     228        
Common stock issued 5,284   $ 2 5,282      
Common stock issued (in shares)     22,222        
Warrants issued, net 3,464     3,464      
Stock-based compensation 1,033     1,033      
Other comprehensive Income (loss) (4)       $ (4)    
Net loss (10,121)         (10,121)  
Balances at Jun. 30, 2020 $ 26,984   $ 4 $ 161,959   $ (134,979)  
Balance (in shares) at Jun. 30, 2020     38,183